Literature DB >> 7426691

Determination of terbutaline in plasma by gas chromatography chemical ionization mass spectrometry.

S E Jacobsson, S Jönsson, C Lindberg, L A Svensson.   

Abstract

A method is described for the determination of unconjugated terbutaline in plasma. The assay is based on gas chromatography chemical ionization mass spectrometry with ammonia as the reagent gas. Terbutaline and a deuterium labelled internal standard were isolated from plasma by ion exchange chromatography followed by extraction into t-butanol. Quantitation was performed by selected ion monitoring of the [MH]+ions m/z 442 and m/z 448 of the tri-O-TMS derivatives of terbutaline and the internal standard, respectively. Silylation was carried out in the presence of pyridine at room temperature and was complete within one minute. The overall recovery of terbutaline in the procedure was estimated at about 80%. Measurement of terbutaline down to 0.1 ng ml-1 in 4 ml of plasma is possible with a coefficient of variation of 8.6%. Day-to-day variation was found to be 6.0% at a level of 3.26 ng ml-1.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426691     DOI: 10.1002/bms.1200070608

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  11 in total

1.  Pharmacokinetics of terbutaline in chronic kidney disease.

Authors:  Anders Bastiansen; Sarah Eggert; Erland Pedersen
Journal:  Eur J Clin Pharmacol       Date:  2013-07-31       Impact factor: 2.953

2.  Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate.

Authors:  L Borgström; L Nyberg; S Jönsson; C Lindberg; J Paulson
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of bambuterol.

Authors:  D S Sitar
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

4.  Terbutaline in breast milk.

Authors:  L O Boréus; P U de Château
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Terbutaline excretion into breast milk.

Authors:  G Lönnerholm; B Lindström
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

6.  A comparison of the clinical and bronchodilating effects of plain and slow-release tablets of terbutaline at steady state.

Authors:  R Pauwels; W Elinck; H Lamont; M van der Straeten; K Ljungholm
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

7.  Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.

Authors:  A P Greefhorst; C L van Herwaarden
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Effects of beta-adrenoceptor stimulation on rectosigmoid motility in man.

Authors:  E Lyrenäs; H Abrahamsson; G Dotevall
Journal:  Dig Dis Sci       Date:  1985-06       Impact factor: 3.199

9.  Pharmacokinetics of terbutaline during pregnancy.

Authors:  S Lyrenäs; A Grahnén; B Lindberg; B Lindström; G Lönnerholm
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  (+) and (-) terbutaline are sulphated at a higher rate in human intestine than in liver.

Authors:  G M Pacifici; M Eligi; L Giuliani
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.